ArticleNucleic acids research2019

New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription.

Ming-Hao Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.